MétaCan
Menu
Back to cohort
Record W4389031870 · doi:10.1093/ofid/ofad500.2424

2813. Impact of a Recent Change in Tobramycin Breakpoints (CLSI) on the Proportion of <i>Pseudomonas aeruginosa</i> Clinical Isolates that are Multidrug-Resistant: CANWARD, 2016 to 2021

2023· article· en· W4389031870 on OpenAlexaffabout
Andrew Walkty, Heather J. Adam, Melanie Baxter, Philippe Lagacé‐Wiens, James A. Karlowsky, George G. Zhanel

Bibliographic record

VenueOpen Forum Infectious Diseases · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicAntibiotic Resistance in Bacteria
Canadian institutionsUniversity of Manitoba
Fundersnot available
KeywordsBroth microdilutionMedicineMeropenemCiprofloxacinMicrobiologyPiperacillin/tazobactamTobramycinCeftazidimeTazobactamPiperacillinMultiple drug resistancePseudomonas aeruginosaMinimum inhibitory concentrationImipenemAntimicrobialAntibioticsAntibiotic resistanceBiologyBacteriaGentamicin

Abstract

fetched live from OpenAlex

Abstract Background Pseudomonas aeruginosa (PA) is an important nosocomial pathogen. In 2023, tobramycin (TM) susceptibility breakpoints for PA were lowered (from ≤4 to ≤1 µg/mL) by the Clinical and Laboratory Standards Institute (CLSI). The purpose of this study was to evaluate whether this change will result in an increase in the proportion of PA clinical isolates that are considered multidrug-resistant (MDR). Methods PA clinical isolates were obtained from patients evaluated at hospitals across Canada (January 2016 to December 2021) as part of an ongoing national surveillance study (CANWARD). Susceptibility testing was carried out using custom broth microdilution panels. MICs were interpreted using current (2023) CLSI breakpoints, with the exception of TM (interpreted using the 2022 and 2023 breakpoints). MDR PA were defined as isolates testing not susceptible at least three of the following: ceftazidime, ciprofloxacin, meropenem, piperacillin-tazobactam, and TM (assessed with both the 2022 and 2023 CLSI breakpoints). Results 1649 PA isolates were included in this study. The proportion of isolates testing susceptible to TM using the 2022 (S ≤4 µg/mL) and 2023 (S ≤1 µg/mL) CLSI breakpoints were 93.6% and 84.8%, respectively. Overall, 21.6% (356/1649) and 22.7% (374/1649) of PA isolates were MDR, using the 2022 and 2023 CLSI breakpoints. Below, the in vitro activities of common antipseudomonal antimicrobials versus PA isolates from this study (all and MDR subset) are presented. Conclusion In this dataset, the proportion of MDR PA isolates was minimally altered by a recent change to the CLSI TM susceptibility breakpoints. A reduction in the proportion of PA isolates that were susceptible to TM using the new breakpoints was most pronounced for the MDR subset. Disclosures George Zhanel, PhD, Avir: Grant/Research Support|Iterum: Grant/Research Support|Merck: Grant/Research Support|Orimed: Grant/Research Support|Paladin Labs: Grant/Research Support|Pfizer: Grant/Research Support|Verity: Grant/Research Support|Zambon: Grant/Research Support

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.695

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.354
Teacher spread0.313 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicAntibiotic Resistance in BacteriaFrench-language works237,207